What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Gene
- Inflammation
Her scientific interests lie mostly in Internal medicine, Endocrinology, Pharmacology, Immunology and Inflammation.
Her Internal medicine research includes themes of Transrepression and Transcription factor.
Her Endocrinology study integrates concerns from other disciplines, such as Bronchoconstriction and Receptor.
The Pharmacology study combines topics in areas such as Anesthesia, Neurotransmitter, Neurotransmitter Agents, Sensory nerve and Bronchodilator.
Maria G. Belvisi has included themes like Neuropeptide, COPD and Lung in her Immunology study.
Maria G. Belvisi interconnects Lipopolysaccharide, Cytokine, In vivo and Glucocorticoid in the investigation of issues within Inflammation.
Her most cited work include:
- ERS guidelines on the assessment of cough (452 citations)
- Neuropeptides in the Respiratory Tract: Part I (413 citations)
- Nitric oxide and lung disease. (395 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns Internal medicine, Endocrinology, Immunology, Pharmacology and Inflammation.
The study incorporates disciplines such as Agonist and Receptor in addition to Endocrinology.
Her Immunology research is multidisciplinary, incorporating perspectives in COPD and Lung.
Her research integrates issues of Capsaicin, Anesthesia, Sensory nerve, Transient receptor potential channel and In vivo in her study of Pharmacology.
Her studies in Sensory nerve integrate themes in fields like Vagus nerve, Guinea pig and Reflex.
Her studies deal with areas such as Tumor necrosis factor alpha, Interferon gamma, Cytokine, Lipopolysaccharide and Pathology as well as Inflammation.
She most often published in these fields:
- Internal medicine (39.05%)
- Endocrinology (34.91%)
- Immunology (34.32%)
What were the highlights of her more recent work (between 2014-2021)?
- Immunology (34.32%)
- Asthma (17.16%)
- Internal medicine (39.05%)
In recent papers she was focusing on the following fields of study:
Maria G. Belvisi mostly deals with Immunology, Asthma, Internal medicine, Transient receptor potential channel and Sensory nerve.
Her Immunology research is multidisciplinary, relying on both Lung and Respiratory system.
Her Asthma study combines topics in areas such as Pathogenesis, Rhinovirus, Virus, CCL17 and Chemokine.
Her Internal medicine research is multidisciplinary, incorporating elements of Endocrinology and Oncology.
Her study in Transient receptor potential channel is interdisciplinary in nature, drawing from both Bronchoconstriction, Biophysics, Bronchospasm and Reflex.
Maria G. Belvisi combines subjects such as Agonist, Chronic cough, Anesthesia and Pharmacology with her study of Sensory nerve.
Between 2014 and 2021, her most popular works were:
- Lung-resident eosinophils represent a distinct regulatory eosinophil subset (182 citations)
- DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease. (70 citations)
- XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough (65 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Inflammation
Her primary areas of investigation include Immunology, Asthma, COPD, Inflammation and Internal medicine.
Her work deals with themes such as TRPV1, Lung, Airway and Pathology, which intersect with Immunology.
Maria G. Belvisi combines subjects such as Capsaicin, Chronic cough and Anesthesia with her study of TRPV1.
Her studies deal with areas such as Immunoglobulin E, Ovalbumin, Immune system and Receptor antagonist as well as Inflammation.
Her Internal medicine research incorporates themes from Endocrinology, Mucin and SOCS3.
The concepts of her Endocrinology study are interwoven with issues in Agonist, Receptor, Methacholine and STAT6.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
